Anebulo Pharmaceuticals, Inc.ANEBNASDAQ
LOADING
|||
ROE: Strong Returns
Trending higher, above historical average, strong compound growth.
Left:
||||
Return on equity
Latest
-72.78%
↑ 26% above average
Average (5y)
-98.57%
Historical baseline
Range
High:-6.23%
Low:-215.13%
CAGR
+63.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | -72.78% | +66.2% |
| 2024 | -215.13% | -94.4% |
| 2023 | -110.67% | -144.3% |
| 2022 | -45.30% | +67.9% |
| 2021 | -141.29% | -2169.1% |
| 2020 | -6.23% | - |